Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NB-001 in Recurrent Herpes Labialis
NCT00453401Phase 2Completed
- Sponsor
- BlueWillow Biologics
- Start
- Feb 2007
- Primary completion
- Dec 2007
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NB-001 in herpes labialis, sponsored by BlueWillow Biologics. Started Feb 2007; status: completed.
02
Drugs
NB-001
03
Conditions
herpes labialis
Beyond the preview
Go deeper on NCT00453401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00453401.